Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal

  • 📰 CNBC
  • ⏱ Reading Time:
  • 69 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 72%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with regulators.

Illumina said it has challenged the European Commission, arguing the agency lacks jurisdiction to block the merger between the two U.S. companies. A final decision is expected in late 2023 or early 2024, the company noted. Illumina said winning a jurisdictional appeal would eliminate any potential fine and "gives the greatest optionality for Illumina to maximize value for shareholders.

last week where Icahn referred to Grail as Illumina's "best equipment." Illumina added that the billionaire investor acknowledged that he doesn't understand the regulatory process and has not offered ideas for a "rapid resolution" for Grail. "Icahn has no ability to accelerate the legal and regulatory processes and neither do his nominees," Illumina said.and found they "lacked relevant skills and experience." That includes Vincent Intrieri, the founder and CEO of VDA Capital Management who was previously employed by Icahn. It also includes General Counsel of Icahn Enterprises Jesse Lynn and Andrew Teno, a portfolio manager at Icahn Capital LP, an entity where Icahn manages investment funds.

Illumina touted Grail in its release, saying it has "tremendous long-term value creation potential." Grail claims to offer the only commercially availablet that can detect more than 50 types of cancers through a single blood draw, Illumina said. The test generated $55 million of revenue in 2022 and is slated to rake in up to $110 million this year, according to Illumina.

The U.K.'s National Health Service is researching the test in a study with 140,000 participants, Illumina added. If the study is successful, the agency expects to test one million people in the U.K. in 2024.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 12. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Report: Nearly Half of 'Climate Change' Companies in U.S. Banked with Failed SVBHalf of the companies in the U.S. devoted to climate change and biotech banked with the now-failed Silicon Valley Bank (SVB). Ahh, the real reason for the bailout has now been revealed, to protect the narrative. They always protect the narrative. Exactly why they received a bailout. Probably half of these companies will be gone in 6-12 months.
Fonte: BreitbartNews - 🏆 610. / 51 Consulte Mais informação »